Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
- Home
- Products
- CRO Service
Quote for CRO Service Specialized CRO Services Protein Expression Services
- Transmembrane Protein Expression Service*
- E.coli Expression System
- Yeast Expression System
- In vitro E.coli Expression System
- Insect Baculovirus Expression System
- Mammalian Cell Expression System
Therapeutic Antibody Discovery Service* Custom Antibody Services- HTP Recombinant Antibody Production
- Recombinant Ab Production
- Monoclonal Ab Production
- Polyclonal Ab Production
- Modified Ab Production
- Anti-idiotype Antibody Production*
-
fasC Antibody
Code CSB-PA332795XA01ENL Size Enquire Have Questions? Leave a Message or Start an on-line Chat Product Details
Full Product NameRabbit anti-Escherichia coli fasC Polyclonal antibodyUniprot No.Target NamesfasCAlternative NamesfasCProtein FasC antibodyRaised inRabbitSpecies ReactivityEscherichia coliImmunogenRecombinant Escherichia coli fasC proteinImmunogen SpeciesEscherichia coliConjugateNon-conjugatedClonalityPolyclonalIsotypeIgGPurification MethodAntigen Affinity PurifiedConcentrationIt differs from different batches. Please contact us to confirm it.BufferPreservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4FormLiquidTested ApplicationsELISA, WB (ensure identification of antigen)ProtocolsTroubleshooting and FAQsStorageUpon receipt, store at -20°C or -80°C. Avoid repeated freeze.Value-added Deliverables① 200ug * antigen (positive control);
② 1ml * Pre-immune serum (negative control);Quality Guarantee① Antibody purity can be guaranteed above 90% by SDS-PAGE detection;
② ELISA titer can be guaranteed 1: 64,000;
③ WB validation with antigen can be guaranteed positive;Lead TimeMade-to-order (14-16 weeks)UsageFor Research Use Only. Not for use in diagnostic or therapeutic procedures.Related Products
Customer Reviews and Q&A
■ Customer ReviewsThere are currently no reviews for this product.
Target Background
FunctionCould be required for the biogenesis of a putative fimbria.Protein FamiliesPeriplasmic pilus chaperone family
Email: [email protected]
Distributors WorldwideTNFR1: Elucidating Dual Mechanisms and Evolving as a Precision Therapeutic Target DLL3: A New Molecular Target in Cancer CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2! TPBG/5T4: the Oncofetal Protein, an Appealing Target for ADC or Vaccine Therapeutics in Tumors! Twice Halted in One Year! Is Akeso's CD73 Monoclonal Antibody in Jeopardy Again? Is PD-1's Golden Partner Still Worth It? GFRAL: A Promising Metabolic Target for Improving Obesity and Anorexia/Cachexia 63.9% Objective Response Rate! B7-H3 Targeted Therapy Transforms Small Cell Lung Cancer Treatment, Domestic Players Compete in Hundred-Billion-Yuan Market SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! Exploring Neurodegeneration: A Comprehensive Guide for Researchers GIPR: the Crucial Regulator of Glucose and Lipid Metabolism in Diabetes and Obesity! Unraveling the Dynamic World of Histone Modifications: Implications in Gene Regulation and Disease Pathogenesis ACE2, The Hottest Target of SARS-CoV-2 Invasion GLP-1R: An Energy Metabolism Regulator of GPCR Family, an Effective Drug Target for Type 2 Diabetes Therapy! TM4SF1: a Member of the Transmembrane-4-Superfamily (L6), a New Vascular Therapeutic Target? LY6G6D (LY6-G): A New Member of Lymphocyte Antigen-6 Family Holds Big Opportunities in Bispecific Antibody for CRC Treatment! Cadherin-17 (CDH17): A Viable Target in Bispecific Antibodies or CAR-T Therapy to Fight Many Gastrointestinal Cancers! Tumor Necrosis Factor (TNF) The Overview of Organelles CDCP1: A Key Mediator for Cell Signaling in Cancers, an Emerging Target for Anti-Tumor Drugs! The "Plaque Cleaner" in Blood Vessels Has Arrived! CD25+ Regulatory T Cells Transform into CAR-Tregs with Amazing Results ENPP3 (CD203c): An Extracellular Enzyme, a Regulator for Nucleotide and Energy, an Indicator for Allergies, an Effective Target for RCC Therapy! Oncostatin M (OSM): A Member of IL-6 Cytokine Family, An Underestimated Player in Future Targeted Therapies? Targeting LRRC15: From tumor microenvironment regulation to fibrotic/infectious disease therapy IL-6: an Important Participant in the Inflammatory Cascade, One of the Most Functional Cytokines in Various Diseases Research! T Cell Activation - The Switch for T Cell Executive Function Major Start to 2026: Impressive Clinical Data for CDH6-Targeting ADC, with Domestic Follow-Ups Close Behind TNFSF15/TL1A: The Rise of the Next Billion-Dollar Target as Pharma Giants Stake Their Claims The Structure, Function, and Research Progress of Lymphotoxin β Receptor (LTBR) in Disease and Drug Development DLL4: A Key Target for Angiogenesis Regulation IL2's 'Double-Edged Sword' Strikes Again: PD1/IL2/VEGF Trispecific Antibodies Emerge at AACR 2026, Nektar's Autoimmune Data Sparks Heated Discussion CCL17: A Chemokine with Multiple Biological Functions Immune Battlefield's "Scout": Decoding the NCR3 Target PTH1R: Key Therapeutic Target in Bone & Metabolic Health B7-H6: A Key Ligand of NK Cell Immune Checkpoints Reshaping the Landscape of Tumor Immunotherapy MICB: a key molecule that bridges cellular stress and immune responses LYPD3: An Emerging Star in Solid Tumor Therapy Parathyroid Hormone (PTH): A Key Target for Regulating Calcium-Phosphate Metabolism and Skeletal Health SEZ6: A New Therapeutic Target for Neuroendocrine Tumors with Multiple ADCs in Clinical Development The Metabolic Achilles' Heel of Cancer Stem Cells: New Mechanism of LGR5 Reveals Metformin's Anticancer Potential Targeting TNFRSF13B: Dual-Target Strategies Usher in New Focus for Treating Tumors and Autoimmune Diseases IL1RAP: Background, Research Mechanisms, Signaling Pathways, Related Diseases, and Latest Advances in Drug Development Groundbreaking! "Cancer Immunol Res": mRNA-LNP Targeting FAP Reprograms T Cells In Vivo, Outperforming Traditional CAR-T in Pancreatic Cancer BTLA: An Emerging Target in Immunotherapy – New Insights into Cancer and Autoimmune Diseases The Multifaceted World of ADAM9: Beyond Proteolytic Function Beyond PD-1? The Potential and Breakthroughs of the Emerging Immune Checkpoint BTLA CDH1/E-cadherin: Research Progress on a Core Target from Adhesion Regulation to Tumor Therapy BTN3A1 (CD277) Target: γδ T Cell Immune Recognition Mechanism and Cancer Immunotherapy Research Progress Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?
© 2007-2026 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
